留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

不同浓度碳酸氢钠联合制霉菌素对系统性红斑狼疮口腔及肺部感染的预防效果

樊育苗 郑朝晖 封朵朵 罗恒 王青

樊育苗, 郑朝晖, 封朵朵, 罗恒, 王青. 不同浓度碳酸氢钠联合制霉菌素对系统性红斑狼疮口腔及肺部感染的预防效果[J]. 中华全科医学, 2026, 24(4): 577-580. doi: 10.16766/j.cnki.issn.1674-4152.004443
引用本文: 樊育苗, 郑朝晖, 封朵朵, 罗恒, 王青. 不同浓度碳酸氢钠联合制霉菌素对系统性红斑狼疮口腔及肺部感染的预防效果[J]. 中华全科医学, 2026, 24(4): 577-580. doi: 10.16766/j.cnki.issn.1674-4152.004443
FAN Yumiao, ZHENG Zhaohui, FENG Duoduo, LUO Heng, WANG Qing. The preventive effect of combining different concentrations of sodium bicarbonate with nystatin on oral and pulmonary infections in SLE patients[J]. Chinese Journal of General Practice, 2026, 24(4): 577-580. doi: 10.16766/j.cnki.issn.1674-4152.004443
Citation: FAN Yumiao, ZHENG Zhaohui, FENG Duoduo, LUO Heng, WANG Qing. The preventive effect of combining different concentrations of sodium bicarbonate with nystatin on oral and pulmonary infections in SLE patients[J]. Chinese Journal of General Practice, 2026, 24(4): 577-580. doi: 10.16766/j.cnki.issn.1674-4152.004443

不同浓度碳酸氢钠联合制霉菌素对系统性红斑狼疮口腔及肺部感染的预防效果

doi: 10.16766/j.cnki.issn.1674-4152.004443
基金项目: 

国家自然科学基金面上项目 62272468

详细信息
    通讯作者:

    王青,E-mail: xjyy112233@163.com

  • 中图分类号: R593.241 R519

The preventive effect of combining different concentrations of sodium bicarbonate with nystatin on oral and pulmonary infections in SLE patients

  • 摘要:   目的  探究不同浓度碳酸氢钠漱口液联合制霉菌素对系统性红斑狼疮(SLE)患者口腔及肺部感染的预防效果,为临床防治提供科学参考。  方法  选取2023年4月—2024年5月中国人民解放军空军军医大学第一附属医院收治的97例SLE患者为研究对象,采用随机数字表法分为A组32例、B组32例、C组33例。A组使用制霉菌素漱口液,B组在A组的基础上加用2%碳酸氢钠漱口液,C组在A组的基础上加用4%碳酸氢钠漱口液。比较3组患者口腔及肺部感染率、感染发生和治愈时间、口腔pH值和疼痛程度。  结果  C组口腔真菌感染率[9.09%(3/33) vs. 37.50%(12/32) vs. 31.25%(10/32)]和肺部真菌感染率[6.06%(2/33) vs. 31.25%(10/32) vs. 25.00%(8/32)]低于A组和B组(P<0.05)。口腔真菌感染、肺部真菌感染发生时间A组<B组<C组,治愈时间A组>B组>C组(P<0.05)。A组和B组口腔感染程度较C组严重(P<0.05)。患者第1天、第5天及第10天含漱后的口腔pH值与VAS评分A组<B组<C组(P组间<0.05),且随着时间延长,VAS评分差异逐渐减小(P交互<0.05)。  结论  4%的碳酸氢钠漱口液联合制霉菌素漱口液可提高SLE患者口腔pH值,降低口腔及肺部真菌感染率,缩短治疗时间,预防效果显著。

     

  • 表  1  3组SLE患者一般资料比较

    Table  1.   Comparison of general characteristics among three groups of SLE patients

    组别 例数 年龄($\bar{x} \pm s$,岁) 性别(男性/女性,例) 病程($\bar{x} \pm s$,月) SLEDAI-2000评分($\bar{x} \pm s$,分)
    A组 32 36.69±5.18 4/28 28.13±5.81 11.91±2.02
    B组 32 36.56±4.93 6/26 28.66±6.88 11.75±2.13
    C组 33 35.97±5.14 3/30 28.15±5.50 12.03±1.96
    统计量 0.186a 1.339b 0.078a 0.154a
    P 0.831 0.512 0.925 0.857
    注:aF值,b为χ2值。
    下载: 导出CSV

    表  2  3组SLE患者口腔及肺部感染率比较[例(%)]

    Table  2.   Comparison of oral and pulmonary infection rates among three groups of SLE patients [cases (%)]

    组别 例数 口腔真菌感染 肺部真菌感染
    A组 32 12(37.50) 10(31.25)
    B组 32 10(31.25) 8(25.00)
    C组 33 3(9.09)ab 2(6.06)ab
    χ2 7.603 6.858
    P 0.022 0.032
    注:与A组比较,aP<0.05;与B组比较,bP<0.05。
    下载: 导出CSV

    表  3  3组SLE患者口腔及肺部感染发生和治愈时间比较($\bar{x} \pm s$,d)

    Table  3.   Comparison of onset and healing time of oral and pulmonary infections among three groups of SLE patients ($\bar{x} \pm s$, d)

    组别 例数 口腔真菌感染 肺部真菌感染
    发生时间 治愈时间 发生时间 治愈时间
    A组 32 17.42±2.84 14.75±2.99 15.60±3.24 16.90±3.67
    B组 32 22.20±5.53a 11.60±3.13a 20.88±4.22a 12.50±2.33a
    C组 33 31.33±2.08ab 7.00±1.00ab 29.00±2.83ab 8.00±1.41ab
    F 14.416 9.308 12.866 9.114
    P <0.001 0.001 <0.001 0.002
    注:与A组比较,aP<0.05;与B组比较,bP<0.05。
    下载: 导出CSV

    表  4  3组SLE患者口腔感染程度比较[例(%)]

    Table  4.   Comparison of oral infection severity among three groups of SLE patients [cases (%)]

    组别 例数 0度 Ⅰ度 Ⅱ度 Ⅲ度 Ⅳ度
    A组 32 20(62.50) 7(21.88) 2(6.25) 2(6.25) 1(3.12)
    B组 32 22(68.75) 5(15.62) 3(9.38) 2(6.25) 0
    C组 33 30(90.91) 2(6.06) 1(3.03) 0 0
    注:3组口腔感染程度比较,H=7.762,P=0.022。
    下载: 导出CSV

    表  5  3组SLE患者口腔真菌感染患者不同时间口腔pH值比较($\bar{x} \pm s$)

    Table  5.   Comparison of oral pH values at different time points among three groups of SLE patients with oral fungal infections ($\bar{x} \pm s$)

    组别 例数 第1天 第5天 第10天 F P
    A组 32 5.08±0.40 5.64±0.44c 6.05±0.41cd 74.886 <0.001
    B组 32 6.07±0.50a 6.75±0.54ac 7.51±0.45acd 50.739 <0.001
    C组 33 7.07±0.15ab 7.73±0.15abc 8.20±0.20abcd 2.073 0.101
    F 31.486 30.615 51.192
    P <0.001 <0.001 <0.001
    注:与A组比较,aP<0.05;与B组比较,bP<0.05;与第1天比较,cP<0.05;与第5天比较,dP<0.05;F时间=123.026,P时间<0.001;F组间=50.739,P组间<0.001;F交互=3.115,P交互=0.064。
    下载: 导出CSV

    表  6  3组SLE患者口腔真菌感染患者不同时间VAS评分比较($\bar{x} \pm s$,分)

    Table  6.   Comparison of VAS scores at different time points among three groups of SLE patients with oral fungal infections ($\bar{x} \pm s$, points)

    组别 例数 第1天 第5天 第10天 F P
    A组 32 3.92±0.51 3.42±0.51c 2.67±0.49cd 119.674 <0.001
    B组 32 4.80±0.63a 4.10±0.74ac 3.10±0.32acd 22.065 <0.001
    C组 33 6.67±0.58ab 5.33±0.58abc 3.67±0.58abcd 6.430 <0.001
    F 29.107 12.074 7.057
    P <0.001 <0.001 0.004
    注:与A组比较,aP<0.05;与B组比较,bP<0.05;与第1天比较,cP<0.05;与第5天比较,dP<0.05;F时间=237.395,P时间<0.001;F组间=22.065,P组间<0.001;F交互=12.836,P交互<0.001。
    下载: 导出CSV
  • [1] 王蝉蝉, 郭婧, 刘丹, 等. 滕秀香教授补肾舒肝理脾法治疗系统性红斑狼疮致卵巢功能减退性疾病经验[J]. 中国临床医生杂志, 2023, 51(11): 1379-1381.

    WANG C C, GUO J, LIU D, et al. Professor Teng Xiuxiang's clinical experience with kidney-nourishing, liver-soothing, and spleen-regulating therapy for systemic lupus erythematosus associated ovarian insufficiency[J]. Chinese Journal For Clinicians, 2023, 51(11): 1379-1381.
    [2] 俞烜华, 张伟桢, 刘昌泉, 等. 系统性红斑狼疮患者淋巴细胞亚群变化与疾病活动的相关性及预测系统损害价值[J]. 中华全科医学, 2025, 23(9): 1555-1560. doi: 10.16766/j.cnki.issn.1674-4152.004176

    YU X H, ZHANG W Z, LIU C Q, et al. Correlation between changes in lymphocyte subsets and disease activity in patients with systemic lupus erythematosus and their value in predicting systemic damage[J]. Chinese Journal of General Practice, 2025, 23(9): 1555-1560. doi: 10.16766/j.cnki.issn.1674-4152.004176
    [3] 张舒晴, 张文博, 赵东宝. 靶向B细胞治疗系统性红斑狼疮研究进展[J]. 中华全科医学, 2025, 23(9): 1565-1568. doi: 10.16766/j.cnki.issn.1674-4152.004178

    ZHANG S Q, ZHANG W B, ZHAO D B. Advancements in B-cell targeted therapies for systemic lupus erythematosus[J]. Chinese Journal of General Practice, 2025, 23(9): 1565-1568. doi: 10.16766/j.cnki.issn.1674-4152.004178
    [4] 付洪杰, 李尊昌, 朱美玉, 等. 康复新液联合碳酸氢钠治疗呼吸重症儿童口腔念珠菌感染的临床疗效[J]. 中华医院感染学杂志, 2022, 32(6): 916-919.

    FU H J, LI Z C, ZHU M Y, et al. Clinical effect of Kangfuxin liquid combined with sodium bicarbonate on treatment of oral Candida infection in children with severe disease[J]. Chinese Journal of Nosocomiology, 2022, 32(6): 916-919.
    [5] MOHAMMADI F, OSHVANDI K, KAMALLAN SR, et al. Effectiveness of sodium bicarbonate and zinc chloride mouthwashes in the treatment of oral mucositis and quality of life in patients with cancer under chemotherapy[J]. Nurs Open, 2022, 9(3): 1602-1611. doi: 10.1002/nop2.1168
    [6] ZHANG L X, MANNING S, WU T T, et al. Impact of nystatin oral rinse on salivary and supragingival microbial community among adults with oral candidiasis[J]. Microorganisms, 2023, 11(6): 1497. DOI: 10.3390/microorganisms11061497.
    [7] 国家皮肤与免疫疾病临床医学研究中心, 中国系统性红斑狼疮研究协作组, 中华医学会风湿病学分会. 中国系统性红斑狼疮诊疗指南(2025版)[J]. 中华医学杂志, 2025, 105(23): 1879-1906.

    National Clinical Research Center for Dermatologic and Immunologic Diseases, Chinese Systemic Lupus Erythematosus Treatment and Research Group, Chinese Rheumatology Association. Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus (2025 edition)[J]. National Medical Journal of China, 2025, 105(23): 1879-1906.
    [8] 牛毓茜, 李桂云, 杨丽秋, 等. 预测重症哮喘患者口腔真菌感染危险因素及列线图预测模型构建[J]. 实用口腔医学杂志, 2022, 38(4): 522-526.

    NIU Y Q, LI G Y, YANG L Q, et al. Prediction of risk factors for oral fungal infection in patients with severe asthma and construction of a nomogram prediction model[J]. Journal of Practical Stomatology, 2022, 38(4): 522-526.
    [9] 中华医学会呼吸病学分会. 侵袭性肺真菌病诊断与治疗指南(2025年版)[J]. 中华结核和呼吸杂志, 2025, 48(12): 1104-1126.

    Chinese Society of Respiratory Diseases. Clinical practice guidelines for the diagnosis and management of invasive pulmonary fungal diseases (2025 Edition)[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2025, 48(12): 1104-1126.
    [10] 王景芳, 郭晓静, 冀金亮. 预见性护理干预在淋巴瘤病人化疗后口腔感染预防中的应用[J]. 护理研究, 2022, 36(4): 727-730.

    WANG J F, GUO X J, JI J L. Application of predictive nursing intervention in the prevention of oral infection in lymphoma patients after chemotherapy[J]. Chinese Nursing Research, 2022, 36(4): 727-730.
    [11] 刘云, 肖菲, 关振群. 炙甘草汤对顽固性复发性口腔溃疡患者的疗效研究[J]. 辽宁中医杂志, 2024, 51(8): 110-113.

    LIU Y, XIAO F, GUAN Z Q. Study on the efficacy of Zhigancao Decoction in patients with refractory recurrent oral ulcers[J]. Liaoning Journal of Traditional Chinese Medicine, 2024, 51(8): 110-113.
    [12] BARBER M R W, FALASINNU T, RAMSEY-GOLDMAN R, et al. The global epidemiology of SLE: narrowing the knowledge gaps[J]. Rheumatol (Oxford), 2023, 62(Suppl 1): i4-i9. DOI: 10.1093/rheumatology/keac610.
    [13] DAI X F, FAN Y T, ZHAO X. Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics[J]. Signal Transduct Target Ther, 2025, 10(1): 102. DOI: 10.1038/s41392-025-02168-0.
    [14] ARZAYUS-PATIÑO L, BENAVIDES-CÓRDOBA V. Non-pharmacological interventions to prevent oropharyngeal candidiasis in patients using inhaled corticosteroids: a narrative review[J]. Healthcare (Basel), 2025, 13(14): 1718. DOI: 10.3390/healthcare13141718.
    [15] 陈冲, 热依拉·艾克兰木, 郭涛. 制霉菌素联合光动力抗菌疗法治疗口腔念珠菌病的疗效及安全性分析[J]. 中国现代医学杂志, 2022, 32(4): 9-13.

    CHEN C, REYILA A, GUO T. The efficacy and safety of nystatin combined with antimicrobial photodynamic therapy on oral candidiasis[J]. China Journal of Modern Medicine, 2022, 32(4): 9-13.
    [16] 申晶晶, 王小平, 王建园. 制霉菌素口腔护理结合健康教育在预防重型肝炎患者口腔真菌感染中的作用[J]. 中国实用护理杂志, 2022, 38(25): 1979-1982.

    SHEN J J, WANG X P, WANG J Y. Effects of nystatin oral care combined with health education in preventing oral fungal infection in patients with severe hepatitis[J]. Chinese Journal of Practical Nursing, 2022, 38(25): 1979-1982.
    [17] RAI A, MISRA S R, PANDA S, et al. Nystatin effectiveness in oral candidiasis treatment: a systematic review & meta-analysis of clinical trials[J]. Life (Basel), 2022, 12(11): 1677. DOI: 10.3390/life12111677.
    [18] DI FEDE O, CANEPA F, MANISCALCO L, et al. Prevention and the treatment of oral mucositis: the efficacy of sodium bicarbonate vs other agents: a systematic review[J]. BMC Oral Health, 2023, 23(1): 4. DOI: 10.1186/s12903-022-02586-4.
  • 加载中
表(6)
计量
  • 文章访问数:  4
  • HTML全文浏览量:  2
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2026-01-06

目录

    /

    返回文章
    返回